A proposal aiming to force pharmaceutical companies to disclose how they set insulin prices cleared its first hurdle at the Nevada Legislature on Wednesday, without a provision that sought a price cap on insulin.
2017 Legislature
MOST READ
A proposal aiming to force pharmaceutical companies to disclose how they set insulin prices cleared its first hurdle at the Nevada Legislature on Wednesday, without a provision that sought a price cap on insulin.